Ania Jastreboff, MD, PhD - Yale School of Medicine
Ania M. Jastreboff, MD, PhD is an Associate Professor in Medicine and Pediatrics at Yale School of Medicine. Dr. Jastreboff is a clinically active physician-scientist and international thought leader in the scientific development and clinical application of novel anti-obesity pharmacotherapeutics revolutionizing obesity treatment.
Ania Jastreboff, MD, PhD - Yale Medicine
Ania M. Jastreboff, MD, PhD, is an adult and pediatric endocrinologist with expertise in obesity medicine and weight management. She cares for patients who have prediabetes, insulin resistance, metabolic syndrome, and type 1 and type 2 diabetes.
Ania Jastreboff - Google Scholar
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 … J …
Obesity Is Not a Choice: A Q&A With Ania Jastreboff - Yale …
Feb 5, 2024 · Ania Jastreboff, MD, PhD, associate professor of medicine (endocrinology), is director of the Yale Obesity Research Center (Y-Weight) and co-director of the Yale Center for Weight Management. She is an international leader in research and clinical application of anti-obesity pharmacotherapeutics.
Ania M. Jastreboff, MD, PhD - Yale New Haven Health
Ania M. Jastreboff, MD, PhD, is an adult and pediatric endocrinologist with expertise in obesity medicine and weight management. She cares for patients who have prediabetes, insulin resistance, metabolic syndrome, and type 1 and type 2 diabetes.
Ania M. Jastreboff, MD, PhD - Endocrine Society
May 19, 2021 · Dr. Jastreboff is a clinically active physician-scientist nationally and internationally recognized for helping to develop the 2016 Clinical Practice Guidelines for The Comprehensive Care of Patients with Obesity (AACE/ACE), educating the next generation of Obesity Medicine physicians by teaching annually at the Harvard Blackburn Treating ...
Ania Jastreboff M.D., Ph.D. - Office of Public Affairs
Dr. Jastreboff’s research includes large, multi-center clinical outcomes trials using novel anti-obesity pharmacotherapeutics and studies examining the neurobiology underlying obesity and mechanisms of anti-obesity medications, including dual hormone receptor agonist tirzepatide and triple hormone receptor agonist retatrutide (NEJM) a novel ...
Ania Jastreboff, MD, PhD - LinkedIn
Nov 13, 2024 · Ania M. Jastreboff, MD, PhD is an Associate Professor in Medicine and Pediatrics at Yale… Utility of Screening Young Adults with Type 1 Diabetes Transitioning to Adult Providers. Hooked on...
Dr. Ania Jastreboff - American Board of Obesity Medicine
Feb 14, 2022 · Ania Jastreboff, MD, PhD, is an Obesity Medicine physician, board certified in Obesity Medicine, adult Endocrinology and Metabolism, and Pediatric
Dr. Ania Jastreboff, MD – New Haven, CT | Endocrinology - Doximity
Dr. Ania Jastreboff, MD is an endocrinologist in New Haven, Connecticut. She is affiliated with Yale-New Haven Hospital.